Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma

Liang, ZY; Li, P; Kang, LQ; Zhou, LL; Xu, Y; Ye, SG; Du, J; Li, B; Wang, YW; Yu, L; Qian, WB; Liang, AB

Liang, AB (通讯作者),Tongji Univ, Dept Hematol, Tongji Hosp, 389 Xincun Rd, Shanghai 200065, Peoples R China.;Yu, L (通讯作者),East China Normal Univ, Sch Chem & Mol Engn, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Inst Biomed Engn & Technol, 3663 North Zhongshan Rd, Shanghai 200065, Peoples R China.;Qian, WB (通讯作者),Zhejiang Univ, Affiliated Hosp 2, Coll Med, Dept Hematol, 88 Jiefang Rd, Hangzhou 310009, Peoples R China.

BLOOD ADVANCES, 2022; 6 (1): 293

Abstract

The malignant plasma cell clone in patients with multiple myeloma (MM) is represented by the production of paraprotein, usually a single abnormal uniq......

Full Text Link